M, Loison
G, Bouhours
F, Fabulas
M, Bougard
M, Delestre
E, Parot-Schinkel
JF, Hamel
A, Venara
Article History
Received: 8 February 2024
Accepted: 17 June 2024
First Online: 20 June 2024
Declarations
:
: The study protocol was submitted to and accepted by a regional committee for the protection of patients (ID-RCB:2021-101016-36) and the study protocol was registered in <i>clinicaltrials.gov</i> under the number NCT04929275.
: Informed consent was collected from each participant to this study.
: Prof. Venara declares conflicts of interest with Takeda, Coloplast, ThermoFisher, Biom’up, and Sanofi-Aventis (consulting and lecture). The other authors have no conflicts of interest to declare.